32.41
+0.99(+3.15%)
Currency In USD
| Previous Close | 31.42 |
| Open | 31.84 |
| Day High | 32.8 |
| Day Low | 31.84 |
| 52-Week High | 49.83 |
| 52-Week Low | 25.47 |
| Volume | 624,496 |
| Average Volume | 1M |
| Market Cap | 1.85B |
| PE | -2.17 |
| EPS | -14.95 |
| Moving Average 50 Days | 30.82 |
| Moving Average 200 Days | 34.91 |
| Change | 0.99 |
If you invested $1000 in Enovis Corporation (ENOV) 10 years ago, it would be worth $685.48 as of October 21, 2025 at a share price of $32.41. Whereas If you bought $1000 worth of Enovis Corporation (ENOV) shares 5 years ago, it would be worth $609.79 as of October 21, 2025 at a share price of $32.41.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million
GlobeNewswire Inc.
Oct 08, 2025 12:15 PM GMT
Wilmington, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced the sale of its Dr. Comfort diabetic shoe business to Promus Eq
Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference
GlobeNewswire Inc.
Sep 08, 2025 8:05 PM GMT
Wilmington, DE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will now present at the Baird 2025 Global Healthcare Conference at 2:35 p.m. ET o
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer
GlobeNewswire Inc.
Apr 02, 2025 10:30 AM GMT
Damien McDonald appointed CEO, effective as of May 12, 2025Company reiterates guidance for first quarter revenues and aEBITDA WIlmington. DE, April 02, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “The Company”) (NYSE: ENOV), a leader